News

The U.S. Food and Drug Administration (FDA) has approved Hulio®, a biosimilar to Humira®. Hulio (adalimumab-fkjp) will be the sixth Humira biosimilar approved for the treatment of many inflammatory conditions...

Even after months of navigating life in the COVID-19 era, keeping up with new information and news can be overwhelming. Below are some of the latest developments surrounding COVID-19 for...

Many of us are overwhelmed by the amount of information available on COVID-19. Keeping up with all of the news can be challenging. Here are some of the top developments...

Our world is still changing every day because of COVID-19. Keeping up with all of the news can be challenging. Here are some of the top COVID-19 updates for people...

The 2020 Fatigue and Health survey has now closed. Thank you for your interest! We are excited to share the results with you soon." Exhaustion, tiredness, weariness... fatigue. We know...

With all of the news circulating about the novel (new) coronavirus, it can be easy to feel overwhelmed or anxious. This is especially true if you are immune-compromised due to...

For those living with chronic health conditions, current news about the coronavirus (COVID-19) can be anxiety-inducing. We have questions and concerns about how the virus is transmitted, how it can...

We know the frustrations of chronic pain. Will you help others understand by taking our survey? Simply put, living with chronic pain is painful. But there is so much more...

You may have noticed that we added a new accessibility feature to our websites. This feature will allow community members to change the size, color, or contrast of the text...

The U.S. Food and Drug Administration (FDA) has approved Hyrimoz for the treatment of plaque psoriasis, psoriatic arthritis (PsA), rheumatoid arthritis (RA), ankylosing spondylitis (AS), Crohn’s disease in adults, ulcerative...

Do you feel heard by your doctor? Do your questions get answered? We want to hear from you! We’re conducting a survey to learn more about your relationship with your...

Cimzia was recently approved by the U.S. Food and Drug Administration (FDA) to treat moderate to severe plaque psoriasis. Cimzia has been previously approved to treat other inflammatory conditions, including...

The US Food and Drug Administration (FDA) has approved the new drug, ILUMYA™, for treatment of plaque psoriasis. ILUMYA, an injectable, has demonstrated significant effectiveness in clinical trials. The announcement...

The weather is changing, leaves are falling and it is that time of year again- open enrollment in the United States! Whether you have private or public health insurance coverage...

Managing symptoms of plaque psoriasis is difficult enough, but emotional and mental challenges can also arise. Often, people aren’t just coping with one chronic condition, but several, and it can...

Have a question about psoriasis and aren’t sure where to turn? The Q&A feature helps you get quick answers and suggestions from other community members. You can search through previously...

You may have noticed some changes around PlaquePsoriasis.com. We’re thrilled to announce that we’ve added some new features and functionality to provide an even better experience for the most important...

The U.S. FDA (Food and Drug Administration) has approved IXIFI (infliximab-qbtx) as a biosimilar to Remicade. IXIFI, manufactured by Pfizer, targets tumor necrosis factor in order to help reduce inflammation...